Michael Koval PhD
- Department of Medicine
Professor
- (404) 712-2976
- mhkoval@emory.edu
- Koval Lab
-
Emory University
Pulmonary Medicine
615 Michael St, 205 Whitehead Building
Overview
My laboratory studies the molecular machinery that regulates gap junctions (coordinating intercellular signaling) and tight junctions (promoting tissue barriers). Understanding how junctions are pathologically misregulated in lung disease enables us to define pharmacologic targets to control the severity of acute lung injury, pulmonary edema and diseases such as Cystic Fibrosis.
Academic Appointment
- Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine
- Professor of Cell Biology, Emory University School of Medicine
Education
Degrees
- PhD from The Johns Hopkins University
- A.B. from University of California
Research
Focus
- My laboratory is defining the molecular machinery that regulates formation of gap junctions (which coordinate intercellular signaling) and tight junctions (which promote tissue barrier function). Understanding how junctions are pathologically misregulated during lung injury will help define control points that can potentially enhance lung cell communication and pulmonary barrier function.
Publications
-
Prostaglandin E Receptor 2 (EP2) Dysregulation in Allergic Fungal Rhinosinusitis Nasal Polyp Epithelium.
Laryngoscope Volume: 135 Suppl 1 Page(s): S1 - S8
04/01/2025 Authors: Smith-Davidson P; Altartoor K; Kabongo MM; Claussen H; Arthur RA; Johnston HR; DelGaudio JM; Wise SK; Solares CA; Barrow EM -
Neurotropic Murine -Coronavirus Infection Causes Differential Expression of Connexin 47 in Oligodendrocyte Subpopulations Associated with Demyelination.
Mol Neurobiol Volume: 62 Page(s): 3428 - 3445
03/01/2025 Authors: Das S; Shaw AK; Das Sarma S; Koval M; Das Sarma J; Maulik M -
Apical integrins as a switchable target to regulate the epithelial barrier.
J Cell Sci Volume: 137
12/01/2024 Authors: Peterson RJ; Reed RC; Zamecnik CR; Sallam MA; Finbloom JA; Martinez FJ; Levy JM; Moonwiriyakit A; Desai TA; Koval M -
Effects of hyperglycemia on airway epithelial barrier function in WT and CF 16HBE cells.
Sci Rep Volume: 14 Page(s): 25095
10/23/2024 Authors: Vazquez Cegla AJ; Jones KT; Cui G; Cottrill KA; Koval M; McCarty NA -
Nanostructure-Mediated Transport of Therapeutics through Epithelial Barriers.
Int J Mol Sci Volume: 25
06/28/2024 Authors: Hansen ME; Ibrahim Y; Desai TA; Koval M -
Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection.
Am J Physiol Lung Cell Mol Physiol Volume: 325 Page(s): L647 - L661
11/01/2023 Authors: Easley KF; Edenfield RC; Lott MEJ; Reed RC; Das Sarma J; Mehta AJ; Staitieh BS; Lipp EK; Cho IK; Johnson SK -
Claudin-23 reshapes epithelial tight junction architecture to regulate barrier function.
Nat Commun Volume: 14 Page(s): 6214
10/05/2023 Authors: Raya-Sandino A; Lozada-Soto KM; Rajagopal N; Garcia-Hernandez V; Luissint A-C; Brazil JC; Cui G; Koval M; Parkos CA; Nangia S -
Ethanol-exposed lung fibroblasts cause airway epithelial barrier dysfunction.
Alcohol Clin Exp Res (Hoboken) Volume: 47 Page(s): 1839 - 1849
10/01/2023 Authors: Sueblinvong V; Fan X; Hart C; Molina S; Koval M; Guidot DM -
The Effects of Endogenous Cannabinoids on the Mammalian Respiratory System: A Scoping Review of Cyclooxygenase-Dependent Pathways.
Cannabis Cannabinoid Res Volume: 8 Page(s): 434 - 444
06/01/2023 Authors: Kolousek A; Pak-Harvey E; Liu-Lam O; White M; Smith P; Henning F; Koval M; Levy JM -
MYOSIN LIGHT CHAIN KINASE DELETION WORSENS LUNG PERMEABILITY AND INCREASES MORTALITY IN PNEUMONIA-INDUCED SEPSIS.
Shock Volume: 59 Page(s): 612 - 620
04/01/2023 Authors: Chihade DB; Smith P; Swift DA; Otani S; Zhang W; Chen C-W; Jeffers LA; Liang Z; Shimazui T; Burd EM